Eisai Japan has entered into a collaboration research agreement with the University of Dundee with a view to discovering new cancer treatments.

The research agreement will focus on Proteolysis Targeting Chimeras (PROTACs) which consist of two linked protein-binding molecules. It is hoped that this research will lead to new drug discoveries for proteins present in cancer, which can be difficult to treat with small molecule inhibitors.

The collaboration will combine the world-leading expertise and technology of the Professor Alessio Ciulli laboratory in PROTACs research at the University, with Eisai’s research and clinical development experience in the oncology field.

Post Navigation